Published in Mutat Res on May 01, 1999
Regulation of cytochrome P450 (CYP) genes by nuclear receptors. Biochem J (2000) 1.74
CYP1A1, CYP2E1, GSTM1, GSTT1, EPHX1 exons 3 and 4, and NAT2 polymorphisms, smoking, consumption of alcohol and fruit and vegetables and risk of head and neck cancer. J Cancer Res Clin Oncol (2007) 1.15
Polymorphisms in metabolic genes, their combination and interaction with tobacco smoke and alcohol consumption and risk of gastric cancer: a case-control study in an Italian population. BMC Cancer (2007) 0.98
Genetic polymorphism of CYP1A2 increases the risk of myocardial infarction. J Med Genet (2004) 0.94
MRI visible drug eluting magnetic microspheres for transcatheter intra-arterial delivery to liver tumors. Theranostics (2015) 0.88
NAT2 polymorphism in Omani gastric cancer patients-risk predisposition and clinicopathological associations. World J Gastroenterol (2007) 0.79
A case-control study investigating the role of sulfotransferase 1A1 polymorphism in head and neck cancer. J Cancer Res Clin Oncol (2006) 0.79
Gene-environment interactions associated with CYP1A1 MspI and GST polymorphisms and the risk of upper aerodigestive tract cancers in an Indian population. J Cancer Res Clin Oncol (2009) 0.77
Association of glutathione S-transferase (GSTM1 and GSTT1) genes with chronic myeloid leukemia. Springerplus (2015) 0.76
Association of CYP1A1, GSTM1 and GSTT1 gene polymorphisms with risk of non-small cell lung cancer in Andhra Pradesh region of South India. Eur J Med Res (2016) 0.75
Grant agencies must be seen to be fair. Nature (1999) 2.03
Central venous catheter-related complications in children with oncological/hematological diseases: an observational study of 418 devices. Ann Oncol (2005) 1.77
Performance status and comorbidity in elderly cancer patients compared with young patients with neoplasia and elderly patients without neoplastic conditions. Cancer (1998) 1.76
Diagnostic value of CYFRA 21-1 tumor marker and CEA in pleural effusion due to mesothelioma. Chest (2001) 1.71
Mechanisms of N-acetylcysteine in the prevention of DNA damage and cancer, with special reference to smoking-related end-points. Carcinogenesis (2001) 1.52
An upper limit on the stochastic gravitational-wave background of cosmological origin. Nature (2009) 1.42
p53 status does not affect sensitivity of human ovarian cancer cell lines to paclitaxel. Cancer Res (1997) 1.31
DNA damage induced by auramine O in liver, kidney, and bone marrow of rats and mice, and in a human cell line (alkaline elution assay and SCE induction). J Toxicol Environ Health (1982) 1.24
Geographical variations of place of death among Italian communities suggest an inappropriate hospital use in the terminal phase of cancer disease. Public Health (2000) 1.19
Oxidative stress and glaucoma: injury in the anterior segment of the eye. Prog Brain Res (2008) 1.15
Induction by carcinogens and chemoprevention by N-acetylcysteine of adducts to mitochondrial DNA in rat organs. Cancer Res (1996) 1.11
Upper limits on a stochastic background of gravitational waves. Phys Rev Lett (2005) 1.11
Modulation of apoptosis by cigarette smoke and cancer chemopreventive agents in the respiratory tract of rats. Carcinogenesis (2001) 1.10
Gene-environment interactions in ocular diseases. Mutat Res (2008) 1.09
Assessing research productivity in an oncology research institute: the role of the documentation center. Bull Med Libr Assoc (1997) 1.08
Studies on DNA binding of caffeine and derivatives: evidence of intercalation by DNA-unwinding experiments. Biochim Biophys Acta (1989) 1.01
Molecular epidemiology of atherosclerosis. FASEB J (1997) 1.00
DDP-induced cytotoxicity is not influenced by p53 in nine human ovarian cancer cell lines with different p53 status. Br J Cancer (1997) 0.99
DNA-damaging activity in vivo and bacterial mutagenicity of sixteen hydrazine derivatives as related quantitatively to their carcinogenicity. Cancer Res (1981) 0.98
Increased invasive, chemotactic and locomotive abilities of c-Ha-ras-transformed human breast epithelial cells. Invasion Metastasis (1991) 0.97
32P-postlabeling detection of DNA adducts in mice treated with the herbicide Roundup. Environ Mol Mutagen (1998) 0.96
Relative survival in elderly cancer patients in Europe. EUROCARE Working Group. Eur J Cancer (1998) 0.96
Treatment of children over the age of one year with unresectable localised neuroblastoma without MYCN amplification: results of the SIOPEN study. Eur J Cancer (2013) 0.95
Aqueous humor oxidative stress proteomic levels in primary open angle glaucoma. Exp Eye Res (2012) 0.95
Chemotaxis of 3T3 and SV3T3 cells to fibronectin is mediated through the cell-attachment site in fibronectin and a fibronectin cell surface receptor. J Cell Biol (1987) 0.95
Glomerular clusterin is associated with PKC-alpha/beta regulation and good outcome of membranous glomerulonephritis in humans. Kidney Int (2006) 0.94
Inhibition of cancer cell growth and c-Myc transcriptional activity by a c-Myc helix 1-type peptide fused to an internalization sequence. Cancer Res (1998) 0.93
Directional limits on persistent gravitational waves using LIGO S5 science data. Phys Rev Lett (2011) 0.93
Physical activity and cancer prevention: a review of current evidence and biological mechanisms. J Prev Med Hyg (2011) 0.92
Cooperation between p53 and hMLH1 in a human colocarcinoma cell line in response to DNA damage. Clin Cancer Res (1999) 0.92
DNA adducts and chronic degenerative disease. Pathogenetic relevance and implications in preventive medicine. Mutat Res (1996) 0.92
The relationship between urban airborne pollution and short-term mortality: quantitative and qualitative aspects. Eur J Epidemiol (2000) 0.91
Impact assessment of oncology research in the European Union. Eur J Cancer (1999) 0.91
The condensation of chromatin in apoptotic thymocytes shows a specific structural change. J Biol Chem (1997) 0.91
Mechanism of resistance to cisplatin in a human ovarian-carcinoma cell line selected for resistance to doxorubicin: possible role of p53. Int J Cancer (1997) 0.89
Patient-tailored treatments with anti-EGFR monoclonal antibodies in advanced colorectal cancer: KRAS and beyond. Curr Cancer Drug Targets (2012) 0.89
Cis and trans regulatory elements in NPHS2 promoter: implications in proteinuria and progression of renal diseases. Kidney Int (2006) 0.88
Enhanced metabolic activation of chemical hepatocarcinogens in woodchucks infected with hepatitis B virus. Carcinogenesis (1989) 0.88
Changes in the expression of cytokeratins and nuclear matrix proteins are correlated with the level of differentiation in human prostate cancer. J Cell Biochem (2000) 0.88
Thermodynamics of condensation of nuclear chromatin. A differential scanning calorimetry study of the salt-dependent structural transitions. Biochemistry (1991) 0.88
Ozone air pollution and daily mortality in Genoa, Italy between 1993 and 1996. Public Health (2005) 0.86
Genomic aberrations in normal appearing mucosa fields distal from oral potentially malignant lesions. Cell Oncol (Dordr) (2011) 0.86
Differences in the proportions of fluoroquinolone-resistant Gram-negative bacteria isolated from bacteraemic children with cancer in two Italian centres. Clin Microbiol Infect (2005) 0.86
Long-term follow-up of neuroblastoma-associated opsoclonus-myoclonus-ataxia syndrome. Neuropediatrics (2009) 0.85
A multi-scale approach to colorectal cancer: from a biochemical- interaction signaling-network level, to multi-cellular dynamics of malignant transformation. Interplay with mutations and onco-protein inhibitor drugs. Curr Cancer Drug Targets (2012) 0.85
Socioeconomic status and survival of gastric cancer patients. Eur J Cancer (1998) 0.85
The immunodepressive activity of N-diazoacetylglycine amide in some transplantation systems. Transplantation (1970) 0.85
Induction of preneoplastic nodules: quantitative predictivity of carcinogenicity. Anticancer Res (1984) 0.85
Cancer biomarkers in human atherosclerotic lesions: no evidence of p53 involvement. Cancer Epidemiol Biomarkers Prev (1995) 0.85
A choline-devoid diet, carcinogenic in the rat, induces DNA damage and repair. Carcinogenesis (1986) 0.84
Analysis of 13 (32)P-DNA postlabeling studies on occupational cohorts exposed to air pollution. Am J Epidemiol (2001) 0.84
Role of H1 in chromatin folding. A thermodynamic study of chromatin reconstitution by differential scanning calorimetry. Biochemistry (1995) 0.84
Limits on gravitational-wave emission from selected pulsars using LIGO data. Phys Rev Lett (2005) 0.84
Benzene adducts with rat nucleic acids and proteins: dose-response relationship after treatment in vivo. Environ Health Perspect (1989) 0.84
[Carcinogenic activity of two N-diazoacetyl derivatives of glycine in newborn Swiss mice]. Boll Soc Ital Biol Sper (1970) 0.84
Quantitative correlations amongst alkaline DNA fragmentation, DNA covalent binding, mutagenicity in the Ames test and carcinogenicity, for 21 compounds. Mutat Res (1982) 0.84
Antioxidant activity and other mechanisms of thiols involved in chemoprevention of mutation and cancer. Am J Med (1991) 0.84
All-sky LIGO search for periodic gravitational waves in the early fifth-science-run data. Phys Rev Lett (2009) 0.84
The immunodepressive activity of Escherichia coli L-asparaginase in some transplantation systems. Cancer Res (1970) 0.84
Less than additive interaction between cigarette smoke and chromium(VI) in inducing clastogenic damage in rodents. Carcinogenesis (2000) 0.83
Production of protein-associated DNA breaks by 8-methoxycaffeine, caffeine and 8-chlorocaffeine in isolated nuclei from L1210 cells: comparison with those produced by topoisomerase II inhibitors. Carcinogenesis (1991) 0.83
Quantitative predictivity of the transformation in vitro assay compared with the Ames test. J Toxicol Environ Health (1984) 0.83
32P-postlabeling detection of aromatic adducts in the white blood cell DNA of nonsmoking police officers. Cancer Epidemiol Biomarkers Prev (1998) 0.83
Multiple points of intervention in the prevention of cancer and other mutation-related diseases. Mutat Res (2001) 0.82
Prevention by N-acetylcysteine of benzo[a]pyrene clastogenicity and DNA adducts in rats. Mutat Res (1991) 0.82
Detection of DNA adducts in human nasal mucosa tissue by 32P-postlabeling analysis. Carcinogenesis (1997) 0.82
SV40 associated miRNAs are not detectable in mesotheliomas. Br J Cancer (2010) 0.82
Role of angiogenesis inhibitors in colorectal cancer: sensitive and insensitive tumors. Curr Cancer Drug Targets (2012) 0.82
Photoactivation of mutagens. Carcinogenesis (1989) 0.82
Predictive ability of the autoradiographic repair assay in rat liver cells compared with the Ames test. J Toxicol Environ Health (1983) 0.82
Comparison of the chemotactic response to conditioned medium of BALB/c3T3 fibroblasts and their SV 40 transformants. Tumori (1985) 0.82
Quantitative predictivity of carcinogenicity for sister chromatid exchanges in vivo. Basic Life Sci (1984) 0.82
Search for gravitational-wave bursts from soft gamma repeaters. Phys Rev Lett (2008) 0.81
Internalization via Antennapedia protein transduction domain of an scFv antibody toward c-Myc protein. FASEB J (2007) 0.81
Relationships between mutation and transformation frequencies in mammalian cells treated "in vitro" with chemical carcinogens. Mutat Res (1977) 0.81
Incidence of pleural mesothelioma in Liguria Region, Italy (1996-2002). Eur J Cancer (2005) 0.81
The PDQ (Physician Data Query), the cancer database, in oncological clinical practice. Cancer Treat Rev (1991) 0.81
Possible implications from results of animal studies in human risk estimations for benzene: nonlinear dose-response relationship due to saturation of metabolism. J Cancer Res Clin Oncol (1987) 0.81
Effect of fenretinide on plasma IGF-I and IGFBP-3 in early breast cancer patients. Int J Cancer (1998) 0.81
DNA-damaging activity in vivo and bacterial mutagenicity of sixteen aromatic amines and azo-derivatives, as related quantitatively to their carcinogenicity. Carcinogenesis (1981) 0.81
Adducts to nuclear DNA and mitochondrial DNA as biomarkers in chemoprevention. IARC Sci Publ (1996) 0.81
Degenerative periodontal-diseases and oral osteonecrosis: the role of gene-environment interactions. Mutat Res (2008) 0.81
PHOX2A and PHOX2B genes are highly co-expressed in human neuroblastoma. Int J Oncol (2008) 0.81
Factors affecting plasma retinol decline during long-term administration of the synthetic retinoid fenretinide in breast cancer patients. Cancer Epidemiol Biomarkers Prev (1994) 0.81
Exposure to agrochemicals and DNA adducts in Western Liguria, Italy. Environ Mol Mutagen (1999) 0.81
A practical procedure for testing DNA damage in vivo, proposed for a pre-screening of chemical carcinogens. Mutat Res (1978) 0.80
Dynamic simulations of pathways downstream of ERBB-family, including mutations and treatments: concordance with experimental results. Curr Cancer Drug Targets (2010) 0.80
Genotoxic and non-genotoxic activities of 2,4- and 2,6-diaminotoluene, as evaluated in Fischer-344 rat liver. Toxicology (1995) 0.80
Structural domains and conformational changes in nuclear chromatin: a quantitative thermodynamic approach by differential scanning calorimetry. Biochemistry (1989) 0.80
Mutagenicity of polycyclic aromatic hydrocarbon fractions extracted from urban air particulates. Mutat Res (1989) 0.80
Changes in the cytoskeletal and nuclear matrix proteins in rat hepatocyte neoplastic nodules in their relation to the process of transformation. Exp Cell Res (1996) 0.80
Prostate cancer incidence and mortality trends among elderly and adult Europeans. Crit Rev Oncol Hematol (2000) 0.80
Mass action and acridine orange staining: static and flow cytofluorometry. J Histochem Cytochem (1979) 0.80
Interferons inhibit chemotaxis of transformed cells and their invasion of a reconstituted basement membrane. Anticancer Res (1987) 0.80
Inhibition of the de-myelinating properties of Aicardi-Goutières syndrome lymphocytes by cathepsin D silencing. Biochem Biophys Res Commun (2012) 0.80
Carcinogen metabolism studies in human bronchial and lung parenchymal tissues. Am Rev Respir Dis (1989) 0.80
A simple model for DNA elution from filters. J Theor Biol (1986) 0.80
Alkaline lysis of mammalian cells for sedimentation analysis of nuclear DNA. Conformation of released DNA as monitored by physical, electron microscopic and enzymological techniques. Biochim Biophys Acta (1975) 0.80